Migdal Insurance & Financial Holdings’s Abeona Therapeutics ABEO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,100	Closed	-$24K	–	610
2022 Q1	$24K	Sell	3,100 -476	-13%	-$3.27K	﹤0.01%	499
2021 Q4	$28K	Sell	3,576 -938	-21%	-$17.2K	﹤0.01%	527
2021 Q3	$124K	Hold	4,514	–	–	﹤0.01%	333
2021 Q2	$178K	Buy	4,514 +788	+21%	+$32.1K	﹤0.01%	323
2021 Q1	$171K	Buy	+3,726	New	+$205K	﹤0.01%	390

Other funds holding ABEO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ABEO Position: Q2 2022 in Review

Migdal Insurance & Financial Holdings sold out of Abeona Therapeutics (ABEO) in Q2 2022, closing a stake of 3,100 shares — an estimated $24K sold.

Migdal Insurance & Financial Holdings first reported a position in ABEO in Q1 2021 and held it in 5 quarters. The position peaked at $178K in Q2 2021. 42 funds tracked by Wall St. Rank hold ABEO as of Q2 2022.

Migdal Insurance & Financial Holdings reported no remaining Abeona Therapeutics position as of Q2 2022 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 3,100 Abeona Therapeutics shares in Q2 2022, an estimated $24K.
Migdal Insurance & Financial Holdings first reported a position in Abeona Therapeutics in Q1 2021 and held it in 5 quarters.
Migdal Insurance & Financial Holdings's Abeona Therapeutics position peaked at $178K in Q2 2021.
42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.